Response to anti-DKK1 therapy in uterine carcinosarcoma: A case report

Response to anti-DKK1 therapy in uterine carcinosarcoma: A case report

Targeted therapies are being increasingly used in clinical practice and trials. However, tumor heterogeneity among sites of metastatic disease can occur creating a conundrum when utilizing biomarker directed therapies. Here we demonstrate a patient with recurrent uterine carcinosarcoma whose local r...

Full description

Bibliographic Details
Main Authors:	A. ElNaggar, N. Zhang, C.B. Scalise, C. Sirard, M.H. Kagey, D. Vaena, R. Arend
Format:	Article
Language:	English
Published:	Elsevier 2022-02-01
Series:	Gynecologic Oncology Reports
Subjects:	Tumor heterogeneity Uterine carcinosarcoma Comprehensive genomic profiling
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352578921002083

Similar Items

Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma
by: Jonathan T. Hunt, et al.
Published: (2021-08-01)

Influence of Clinical and Surgical Factors on Uterine Carcinosarcoma Survival
by: Myriam Gracia, et al.
Published: (2023-02-01)

Prognostic Value of Lymph Node Ratio in Patients with Uterine Carcinosarcoma
by: Rasiah Bharathan, et al.
Published: (2024-01-01)

Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas
by: İrfan Cicin, et al.
Published: (2016-10-01)

Uterine Carcinosarcoma Associated with Tamoxifen Use in a Menopausal ‎Patient: A Case Report ‎
by: T Ashrafganjoei, et al.
Published: (2015-12-01)

Uterine cervical carcinosarcoma; very rare and aggressive behavior; literature review
by: Özer Birge, et al.
Published: (2021-04-01)

Uterine carcinosarcoma associated with a germline nibrin (NBN) mutation
by: Tahireh Markert, et al.
Published: (2022-04-01)

Clinically aggressive “low-grade” uterine carcinosarcoma: A case report
by: Theresa Clearman, et al.
Published: (2015-11-01)

OSucs: An Online Prognostic Biomarker Analysis Tool for Uterine Carcinosarcoma
by: Yang An, et al.
Published: (2020-09-01)

Delayed and clinically isolated port site carcinosarcoma recurrence as an early indicator of disseminated disease
by: Monica Dandapani, et al.
Published: (2015-11-01)

Secondary uterine carcinosarcoma after concurrent chemoradiotherapy for cervical cancer: Case reports
by: Akihiko Wakayama, et al.
Published: (2017-08-01)

Outcome and predictive factors in uterine carcinosarcoma using postoperative radiotherapy: a Rare Cancer Network study
by: Daniel R. Zwahlen, et al.
Published: (2016-06-01)

A personalized nomogram for predicting 3-year overall survival of patients with uterine carcinosarcoma in a tertiary care hospital in Southern Thailand
by: Kulisara Nanthamongkolkul, et al.
Published: (2023-05-01)

cERBB-2/Her-2 Neu Overexpression and Prognostic Significance in Uterine Carcinosarcoma
by: Huseyin Salih SEMIZ, et al.
Published: (2023-01-01)

Carcinosarcoma of the Uterine Corpus with Alpha-Fetoprotein-Producing Hepatoid Adenocarcinoma: A Report of Two Cases
by: Ryuji Kawaguchi, et al.
Published: (2011-07-01)

Uterine carcinosarcoma associated with pelvic radiotherapy for sacral chordoma: A case report
by: Korhan Kahraman, et al.
Published: (2012-03-01)

Effect of Adjuvant Therapy on Oncologic Outcomes of Surgically Confirmed Stage I Uterine Carcinosarcoma: a Turkish Gynecologic Oncology Study
by: Günsu Kimyon Cömert, et al.
Published: (2019-07-01)

Non-islet cell tumor hypoglycemia in a patient with uterine carcinosarcoma
by: Miller P. Singleton, et al.
Published: (2022-02-01)

Outcome of adjuvant radiotherapy after total hysterectomy in patients with uterine leiomyosarcoma or carcinosarcoma: a SEER-based study
by: Yuan Li, et al.
Published: (2019-07-01)

Survival analysis of patients with rare tumors of the uterine corpus – carcinosarcoma
by: Stevanović Nemanja, et al.
Published: (2024-01-01)

Gemcitabine combination therapies induce apoptosis in uterine carcinosarcoma patient-derived organoids
by: Matías J. Dahl, et al.
Published: (2024-03-01)

Comparative analysis of EZH2, p16 and p53 expression in uterine carcinosarcomas
by: Evelin Makk, et al.
Published: (2023-12-01)

Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?
by: Laura Gonzalez dos Anjos, et al.
Published: (2018-09-01)

Radiation-Induced Uterine Carcinosarcoma after Concurrent Chemoradiotherapy for Cervical Squamous Cell Carcinoma
by: Joana Moreira-Barros, et al.
Published: (2018-12-01)

Progestin and aromatase inhibitor therapy in recurrent, estrogen/progestin receptor positive uterine carcinosarcoma: A case report
by: Angela L. Liang, et al.
Published: (2021-11-01)

Sinonasal Teratoid Carcinosarcoma
by: Jose M. Carnate
Published: (2007-11-01)

HER2 Oncogene as Molecular Target in Uterine Serous Carcinoma and Uterine Carcinosarcoma
by: Blair McNamara, et al.
Published: (2023-08-01)

Clinical and multiparametric MRI features for differentiating uterine carcinosarcoma from endometrioid adenocarcinoma
by: Xiaodan Chen, et al.
Published: (2024-02-01)

The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas
by: Lea A. Moukarzel, et al.
Published: (2021-04-01)

HER2 amplification in Uterine carcinosarcoma after tamoxifen therapy: a case report
by: Fuqiang Zheng, et al.
Published: (2023-12-01)

Trends in Gynecologic Carcinosarcoma Based on Analysis of the Surveillance Epidemiology End Result (SEER) Database
by: Joo Won Lee, et al.
Published: (2023-02-01)

Carcinosarcoma of lung
by: S Neupane, et al.
Published: (2013-03-01)

Patterns of adjuvant treatment and survival outcomes in stage I uterine carcinosarcoma
by: Lori Cory, et al.
Published: (2022-02-01)

Monitoring Treatment Response, Early Recurrence, and Survival in Uterine Serous Carcinoma and Carcinosarcoma Patients Using Personalized Circulating Tumor DNA Biomarkers
by: Stefania Bellone, et al.
Published: (2023-05-01)

Therapeutic Challenges in Patients with Gynecologic Carcinosarcomas: Analysis of a Multicenter National Cohort Study from the French Prospective TMRG Network
by: Clémence Romeo, et al.
Published: (2022-01-01)

Insights into Clinical Features and Outcomes of Adrenal Cortical Carcinosarcoma
by: Zachery Branham, et al.
Published: (2022-10-01)

Breast Carcinosarcomas
by: Savaş Yakan, et al.
Published: (2014-07-01)

Pure abscopal effect in a patient with advanced uterine carcinosarcoma
by: Kazuhiro Okamoto, MD, et al.
Published: (2023-07-01)

Adjuvant therapy and prognosis in uterine carcinosarcoma
by: Chi-Yuan Chiang, et al.
Published: (2021-11-01)

Carcinosarcoma of the Maxillary Sinus
by: Jeong-Ki Moon, et al.
Published: (2013-06-01)